Cytochrome P450 Epoxygenase CYP2J2 and the Risk of Coronary Artery Disease

Trends in Cardiovascular Medicine

Volumn 16, Issue 6, 2006, Pages 204-208

  Spiecker, Martin ^a   Liao, JamesK ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 8,9 EPOXYICOSATRIENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; CYTOKINE; EPOXYICOSATRIENOIC ACID; ICOSANOID; ICOSATRIENOIC ACID; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CORONARY ARTERY DISEASE; DRUG SYNTHESIS; ENDOTHELIUM; GENE EXPRESSION; GENETIC POLYMORPHISM; HEART; HEART MUSCLE CELL; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; VASODILATATION;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; OXYGENASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 33745741899     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.04.001     Document Type: Review

References (44)

1. Abraham N., Pinto A., Levere R., and Mullane K. Identification of heme oxygenase and cytochrome P-450 in the rabbit heart. J Mol Cell Cardiol 19 (1987) 73-81
2. Bauersachs J., Popp R., Hecker M., et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94 (1996) 3341-3347
3. Bauersachs J., Christ M., Ertl G., et al. Cytochrome P450 2C expression and EDHF-mediated relaxation in porcine coronary arteries is increased by cortisol. Cardiovasc Res 54 (2002) 669-675
4. Berliner J., Navab M., Fogelman A., et al. Atherosclerosis basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
5. Brand K., Page S., Rogler G., et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97 (1996) 1715-1722
6. Campbell W., Gebremedhin D., Pratt P., and Harder D. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78 (1996) 415-423
7. Capdevila J., Chacos N., Werringloer J., et al. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci U S A 78 (1981) 5362-5366
8. Capdevila J., Karara A., Waxman D., et al. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem 265 (1990) 10865-10871
9. Chen J., Capdevila J., Zeldin D., and Rosenberg R. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 55 (1999) 288-295
10. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 68 (1993) 499-508
11. Cybulsky M., and Gimbrone M. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251 (1991) 788-791
12. Daikh B., Lasker J., Raucy J., and Koop D. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 271 (1994) 1427-1433
13. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 (1999) 493-497
14. Fisslthaler B., Hinsch N., Chataigneau T., et al. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 36 (2000) 270-275
15. Fisslthaler B., Michaelis U., Randriamboavonjy V., et al. Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression. Biochim Biophys Acta 1619 (2003) 332-339
16. Fleming I., Michaelis U., Bredenkotter D., et al. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88 (2001) 44-51
17. Guengerich F., and Mason P. Immunological comparison of hepatic and extrahepatic cytochromes P-450. Mol Pharmacol 15 (1979) 154-164
18. Keeney D., Skinner C., Wei S., et al. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J Biol Chem 273 (1998) 9279-9284
19. King L., Ma J., Srettabunjong S., et al. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol 61 (2002) 840-852
20. Laethem R., and Koop D. Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases. Mol Pharmacol 42 (1992) 958-963
21. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
22. Nguyen X., Wang M., Reddy K., et al. Kinetic profile of the rat CYP4A isoforms arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol 276 (1999) R1691-R1700
23. Nishikawa Y., Stepp D., and Chilian W. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279 (2000) H459-H465
24. Nithipatikom K., Moore J., Isbell M., et al. Epoxyeicosatrienoic acids (EETs) in cardioprotection ischemic versus reperfusion injury. Am J Physiol Heart Circ Physiol (2006) (in press)
25. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285 (1999) 1276-1279
26. mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276 (2001) 15983-15989
27. Oltman C., Weintraub N., VanRollins M., and Dellsperger K. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83 (1998) 932-939
28. Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301 (1983) 569-574
29. Ridker P., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
30. Rifkind A., Lee C., Chang T., and Waxman D. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320 (1995) 380-389
31. Ross R., and Harker L. Hyperlipidemia and atherosclerosis. Science 193 (1976) 1094-1100
32. + channels and p42/p44 MAPK pathway. Circ Res (2004)
33. Spiecker M., Darius H., H T., et al. Risk of coronary artery disease associated with polymorphism of a cytochrome P450 epoxygenase, CYP2J2. Circulation 110 (2004) 2132-2136
34. Spiecker M., and Liao J. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 433 (2005) 413-420
35. Stegeman J., Woodin B., Klotz A., et al. Cytochrome P-450 and monooxygenase activity in cardiac microsomes from the fish stenotomus chrysops. Mol Pharmacol 21 (1982) 517-526
36. Sun J., Sui X., Bradbury J., et al. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90 (2002) 1020-1027
37. Thompson C., Capdevila J., and Strobel H. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exp Ther 294 (2000) 1120-1130
38. Wang Y., Wei X., Xiao X., et al. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314 (2005) 522-532
39. Wu S., Moomaw C., Tomer K., et al. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271 (1996) 3460-3468
40. Wu S., Chen W., Murphy E., et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272 (1997) 12551-12559
41. 2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2. Mol Pharmacol 66 (2004) 1607-1616
42. Yang B., Graham L., Dikalov S., et al. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60 (2001) 310-320
43. Zeldin D. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276 (2001) 36059-36062
44. Zeldin D., DuBois R., Falck J., and Capdevila J. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys 322 (1995) 76-86